html5-img
1 / 53

Pleuritic chest pain and shortness of breath one week post-hysterectomy

Pleuritic chest pain and shortness of breath one week post-hysterectomy. History suggests pulmonary embolus PE is important diagnosis to make because untreated PE has risk of death due to additional PE, and anticoagulation decreases that risk

jrouse
Télécharger la présentation

Pleuritic chest pain and shortness of breath one week post-hysterectomy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pleuritic chest pain and shortness of breath one week post-hysterectomy

  2. History suggests pulmonary embolus • PE is important diagnosis to make because untreated PE has risk of death due to additional PE, and anticoagulation decreases that risk • On the other hand, if patient doesn’t have PE, anticoagulating patient gives them risk of serious bleeding for no benefit • D-dimer might be considered as a screen, but it is non-specific and in this patient may be elevated just because of recent surgery • Imaging plays big role in making the big decision: anticoagulate or not • What is initial imaging study?

  3. Start with CXR • Even though CXR is insensitive in diagnosis of PE (most common CXR finding in patient with PE is normal, as on following CXR) • And even though the most common CXR findings in PE patients are usually nonspecific (pleural effusion, consolidation, atelectasis) • Do the CXR to R/O other causes for symptoms (e.g., pneumothorax), and should have baseline CXR with potentially serious cardiopulmonary disease, in case patient goes bad. Also CXR will often be needed to interpret V/Q scan if done subsequently

  4. Following CXR is on same patient whose CXR was initially normal, but now with left basilar opacity • This is at least partly due to pleural effusion because of associated meniscus, but effusion is not specific to PE, having many other causes as well

  5. Old gold standard test for PE was catheter pulmonary angiography, now seldom done • It showed PE as filling defect in pulmonary artery otherwise opacified with contrast, as illustrated in the following image (same patient as on preceding CXRs) • Currently contrast-enhanced CT is often used as the next imaging test, if PE is still possible after CXR. CT shows PE in same way that catheter angio had done in the past, but non-invasively

  6. Because key question is anticoagulate or not, some algorithms start with Doppler US of leg veins • If US is positive for DVT, then the key question is answered (patient needs anticoagulation), although there is still some uncertainty as to whether patient had PE, and if so how big • Other problem with US is that about half of patients with PE will have negative leg venous US • US is very useful in pregnant patients (radiation concerns)

  7. Following image shows deep venous thrombosis (common femoral vein) • DVT is recognized on US by lack of full compressibility of deep veins (as illustrated here) and lack of flow on color Doppler

  8. If patient can’t have contrast-enhanced chest CT (contrast allergy, renal insufficiency), V/Q (ventilation/perfusion) scan is older but still commonly used alternative • Ventilation scan done by having patient breathe in radioactive gas (as in following image) or radioactive aerosol • Perfusion scan done by injecting radio-labelled microemboli (macro-agregated albumin in this case) into systemic vein, so that the emboli lodge in the first capillary bed they reach (the lungs if there is no right-to-left shunt)

  9. Perfusion scan is sensitive but nonspecific because other pathologies can cause perfusion defects, such as airway disease (if part of lung is hypoventilated, hypoxia in that area will cause pulmonary arterial constriction, shunting blood away, resulting in perfusion defect) • Ventilation scan allows recognition of airway disease, improving specificity of perfusion scan

  10. Following 2 frames show a V/Q scan with a high probability of PE • Ventilation scan is normal (symmetrical lung filling on single breath, prompt symmetrical washout without air trapping) • Perfusion scan is picture of pulmonary blood flow frozen in time, allowing images to be taken from multiple angles (anterior, posterior, both laterals, both posterior obliques) • Note wedge-shaped perfusion defects in lingula of LUL and apical segment of LLL • This is high probability of PE because there are multiple segmental wedge-shaped perfusion defects unmatched by ventilation defects

  11. Because the perfusion scan is so sensitive, V/Q scans are very helpful when normal, effectively ruling out PE • V/Q scans also helpful when resulting in a high-probability reading associated with a high clinical suspicion (chance of PE is 96% -> anticoagulate) • V/Q scans also helpful when resulting in a low-probability reading associated with a low clinical suspicion (chance of PE is 4% -> withhold anticoagulation • Unfortunately most V/Q scans are other than normal, high-high or low-low, in part because ED patients with chest pain and shortness of breath include many who have lung disease which causes abnormal V/Q scans in the absence of PE • V/Q scans are most helpful in patients with no evidence of lung disease on history (non-smoker, no asthma), exam (clear lungs), and CXR (normal lungs). Because 90% of ED patients with ? of PE don’t have PE, if they don’t have lung disease otherwise, their V/Q scan will probably be normal (a powerful result ending the PE W/U).

  12. Usual imaging test to follow CXR in PE W/U is contrast-enhanced chest CT, the new gold-standard, replacing old catheter angiogram • Multi-detector spiral CT on modern scanners results in multi-planar images that are usually diagnostic even in patients who can’t suspend respiration • If PE is not shown on good quality CT, diagnosis has essentially been ruled out, and patient has no increased risk of death from subsequent PE if not anticoagulated

  13. BREAST IMAGING

  14. Screening asymptomatic women for early breast CA is meant to decrease deaths from the disease • Topic continues to be very controversial • Am Cancer Society recommends screening with physical exam by trained health pro and mammography (annually starting age 40 in average risk patient) • Others recommend starting mammo later and only every 2 years • Mammo screening probably prevents only about 30% of potential deaths related to breast CA (for most breast CAs, death or survival will occur regardless of whether mammo is done or not)

  15. Screening mammo consists of 2 images, one from above (craniocaudal, to cover medial breast) and one in oblique projection (medio-lateral oblique, to cover axillary tail of breast) • Views done with compression, sometimes uncomfortable for patient, but important to decrease motion blurring, decrease necessary radiation dose, and separate possible CA from overlying glandular tissue

  16. Following image is normal CC projection • This breast is composed mostly of fat (hence the visibility of blood vessels in this case)

  17. Following image is normal MLO projection on different patient • Note that this patient has a dense breast composed mainly of fibroglandular tissue and relatively little fat

  18. One of the main findings of breast CA on mammo is a dominant mass that stands out from the background pattern of normal glandular densities • Following image shows an obvious CA presenting as a mass, easily seen in this breast which is mostly fat • This same mass might be invisible if present in a breast composed mostly of dense fibroglandular tissue

  19. The problem of dense tissue obscuring CA on mammography is why the overall sensitivity of mammo for breast CA detection is no better than 75-80% • Therefore, physical exam is still important as a complement to mammography when screening for breast CA • A suspicious finding on physical exam should not be discounted in the face of a normal mammogram reading, particularly if breast has a lot of normal dense fibroglandular tissue (it may still be a cancer!) • In Connecticut and many other states, breast density must be reported on the mammo dictation

  20. Mammographic Breast Density Classes • 1. Almost Entirely Fat (0-25% dense) – 10% of cases • 2. Scattered Fibroglandular Densities (25-50% dense) – 40% of cases • 3. Heterogeneously Dense (50-75% dense) – 40% of cases • 4. Extremely Dense (75-100% dense) – 10% of cases

  21. Following are 4 normal CC mammo images from patients representing the 4 classes of breast density • Breast density tends to decrease with age, mostly a reflection of weight gain and more fat deposition • However, young obese patients may have fatty breasts and thin elderly patients may have dense breasts (the fourth image below is from an 80-yr-old patient)

  22. Sensitivity of mammography for breast CA detection is very good (97-98%) in the “Almost Entirely Fat” breast • However, in the “Extremely Dense” breast the sensitivity is only 30-60% (it’s a polar bear in a snowstorm)

  23. In addition to a dominant mass, the other main mammographic sign of breast CA is clustered microcalcifications (this is dystrophic calcification in debris resulting from cellular necrosis, which is often associated with cancers that outgrow their blood supply) • Although benign calcifications of many causes are common on mammo, clustered microcalcifications are suspicious for CA, particularly if they are irregular, poorly defined, linear/branching, and new on comparison with prior imaging

  24. Following mammo image shows malignant clusterdmicrocalcifications in upper part of image • Note that there are also benign calcifications, including arterial atherosclerotic calcifications in lower part of image

  25. Because mammo findings fall on a continuous spectrum of suspicion (from normal to obvious CA), essentially all mammo reports will have a final Category reading given at the end of the dictation • The Category reading is required by the FDA (all mammo facilities in USA must be accredited by FDA) • The Category indicates the level of suspicion, and the recommended F/U • Category 0 means the W/U is not finished (may need diagnostic mammo with additional mammo views, or US, before final Category reading is given) • Category 1 and 2 indicate return to routine annual screening • Category 3 is a low suspicion lesion that usually is re-imaged in 6 months instead of 12 • Category 4 and 5 are suspicious enough that needle biopsy is indicated

  26. Mammo Reading Categories • Required by FDA • Category • 0 Incomplete: Need Additional Imaging Evaluation • 1 Negative • 2 Benign Finding • 3 Probably Benign, Short Interval Follow- Up Indicated • 4 Suspicious for Malignancy (do biopsy) • 5 Highly Suggestive of Malignancy (do biopsy)

  27. Biggest problem with mammo as screening test is its poor sensitivity 75-80%) • However, its positive predictive value is also poor • Only about 25% of patients recommended to have needle biopsy turn out to have CA

  28. Following diagnostic mammo image done for patient with palpable mass (marked with BB) • The mass is hard to see because of superimposed fibroglandular tissue • This is situation where US has traditionally been used (to characterize mass, felt on exam or seen on mammo, as cyst or solid)

  29. Following image shows that mass on preceding mammo is typical cyst (no internal echoes, sharp back wall, good sound transmission, orientation parallel to skin) • Cyst is much more common cause of breast mass than CA

  30. Because US can detect CAs not visible on mammo (hidden by normal dense tissue), US may be used as supplement to mammo to screen for breast CA • US can see CAs within dense glandular tissue, mammo’s weak point • This practice is not universally accepted because although additional CAs are found on US, it has not been proven that this decreases death from breast CA • However, use of US to screen for CA in patients with mammographically dense breasts is increasing and is in common use in Connecticut • Although by itself US sensitivity for breast CA detection is about the same as mammo, because they pick up different cancers, mammo and US are complementary and together have a higher sensitivity than either one alone

  31. Following image shows a typical CA within glandular tissue • Note that this solid lesion does not look like a cyst (internal echoes, irregular wall, decreased sound transmission, orientation perpendicular to skin)

More Related